96
Views
4
CrossRef citations to date
0
Altmetric
Original Research

How to Implement Adherence-Promoting Programs in Clinical Practice? A Discrete Choice Experiment on Physicians’ Preferences

ORCID Icon, ORCID Icon, , , , , ORCID Icon & ORCID Icon show all
Pages 267-276 | Published online: 14 Feb 2020

References

  • Dunbar-Jacob J, Erlen JA, Schlenk EA, et al. Adherence in chronic disease. Annu Rev Nurs Res. 2000;18:48–90. doi:10.1891/0739-6686.18.1.48
  • WHO. Adherence to Long-Term therapies;Evidence for Action. World Health Organisation; 2003.
  • Müller S, Kohlmann T, Wilke T. Validation of the Adherence Barriers Questionnaire - An instrument for identifying potential risk factors associated with medication-related non-adherence Quality, performance, safety and outcomes. BMC Health Serv Res. 2015;15:1–22. doi:10.1186/s12913-015-0809-0
  • van Boven JF, Chavannes NH, Van der Molen T, et al. Clinical and economic impact of non-adherence in COPD: a systematic review. Respir Med. 2014;108:103–113. doi:10.1016/j.rmed.2013.08.044
  • McHorney CA, Peterson ED, Ashton V, et al. Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patients. Curr Med Res Opin. 2018. doi:10.1080/03007995.2018.1530205
  • Perez-Ruiz F, Desideri G. Improving adherence to gout therapy: an expert review. Ther Clin Risk Manag. 2018;14:793–802. doi:10.2147/TCRM.S162956
  • Mueller S, Wilke T, Gorasso V, Erhart M, Kittner JM. Adaption and validation of the adherence barriers questionnaire for HIV patients on antiretroviral therapy (ABQ-HIV). BMC Infect Dis. 2018;18:599. doi:10.1186/s12879-018-3530-x
  • Ammoury A, Okais J, Hobeika M, et al. Adherence to systemic therapies for immune-mediated inflammatory diseases in Lebanon: a physicians’ survey from three medical specialties. Patient Prefer Adherence. 2017;11:939–945. doi:10.2147/PPA
  • Rozenblum R, Gianola A, Ionescu-Ittu R, et al. Clinicians’ perspectives on patient satisfaction in adult congenital heart disease clinics–a dimension of health care quality whose time has come. Congenit Heart Dis. 2015;10:128–136. doi:10.1111/chd.2015.10.issue-2
  • Chapman KR, Hinds D, Piazza P, et al. Physician perspectives on the burden and management of asthma in six countries: the Global Asthma Physician Survey (GAPS). BMC Pulm Med. 2017;17:153. doi:10.1186/s12890-017-0492-5
  • Fuangchan A, Dhippayom T, Kongkaew C. Intervention to promote patients’ adherence to antimalarial medication: a systematic review. Am J Trop Med Hyg. 2014;90:11–19. doi:10.4269/ajtmh.12-0598
  • Costa E, Pecorelli S, Giardini A, et al. Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence. 2015;9:1303–1314. doi:10.2147/PPA
  • Abdulsalim S, Unnikrishnan MK, Manu MK, et al. Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study. Res Social Adm Pharm. 2018;14:909–914. doi:10.1016/j.sapharm.2017.10.008
  • Boswell KA, Cook CL, Burch S, Eaddy M, Cantrell C. Associating medication adherence with improved outcomes: a systematic literature review. Am J Pharm Benefits. 2012;4:e97–e108.
  • Muhlbacher A, Johnson FR. Choice experiments to quantify preferences for health and healthcare: state of the practice. Appl Health Econ Health Policy. 2016;14:253–266. doi:10.1007/s40258-016-0232-7
  • Johnson FR, Lancsar E, Marshall D, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force. Value Heal. 2013;16:3–13. doi:10.1016/j.jval.2012.08.2223
  • Mueller S, Agostini H, Ehlken C, et al. Patient preferences in the treatment of neovascular age-related macular degeneration: a discrete choice experiment. Ophthalmology. 2016;123:876–883. doi:10.1016/j.ophtha.2015.12.001
  • Bottger B, Thate-Waschke I-M, Bauersachs R, Kohlmann T, Wilke T. Preferences for anticoagulation therapy in atrial fibrillation: the patients’ view. J Thromb Thrombolysis. 2015;40:406–415. doi:10.1007/s11239-015-1263-x
  • Louviere JJ, Flynn TN, Carson RT. Discrete Choice Experiments Are Not Conjoint Analysis. J Choice Model. 2010;3:57–72. doi:10.1016/S1755-5345(13)70014-9
  • Hensher D, Irwin J. Combining sources of preference data for modeling complex decision processes. Marketing Lett. 1999;3:205–217.
  • Bennett J, Blamey RK, editors. The choice modelling approach to environmental valuation: new horizons in environmental valuation. Cheltenham: Edward Elgar: New Horizons in Environmental Economics. 2001:40.
  • Conjoint Analysis – attribute Importance | SurveyAnalytics Help Document. Available from: https://www.surveyanalytics.com/help/conjoint-analysis-attribute-importance.html. Accessed November 13, 2019.
  • Devine F, Edwards T, Feldman SR. Barriers to treatment: describing them from a different perspective. Patient Prefer Adherence. 2018;12:129–133. doi:10.2147/PPA.S147420
  • Rahman S, Majumder A, Shaban S, et al. Physician participation in clinical research and trials: issues and approaches. Adv Med Educ Pract. 2011;2:85–93. doi:10.2147/AMEP
  • Sicsic J, Krucien N, Franc C. What are GPs’ preferences for financial and non-financial incentives in cancer screening? Evidence for breast, cervical, and colorectal cancers. Soc Sci Med. 2016;167:116–127. doi:10.1016/j.socscimed.2016.08.050
  • Deal K, Keshavjee K, Troyan S, Kyba R, Holbrook AM. Physician and patient willingness to pay for electronic cardiovascular disease management. Int J Med Inform. 2014;83:517–528. doi:10.1016/j.ijmedinf.2014.04.007
  • Joosten E, de Weert G, Sensky T, van der Staak C, de Jong C. Effect of shared decision-making on therapeutic alliance in addiction health care. Patient Prefer Adherence. 2008;2:277–285. doi:10.2147/PPA.S4149